| 6395509 |
DNA encoding Rhesus ob protein |
Margret B. Basinski |
2002-05-28 |
$59,864,000 |
| 6323178 |
Beta-lipotropin methods |
John Hale, Mark L. Heiman, William F. Heath, Jr. |
2001-11-27 |
$246,878,000 |
| 5851995 |
Anti-obesity proteins |
Margret B. Basinski, Richard D. DiMarchi, David B. Flora, William F. Heath, Jr., James A. Hoffmann +2 more |
1998-12-22 |
$170,171,000 |
| 5691309 |
Anti-obesity proteins |
Margret B. Basinski, Richard D. DiMarchi, David B. Flora, William F. Heath, Jr., James A. Hoffmann +2 more |
1997-11-25 |
$74,311,000 |
| 5605886 |
Anti-obesity proteins |
Margret B. Basinski, Richard D. DiMarchi, David B. Flora, William F. Heath, Jr., James A. Hoffmann +2 more |
1997-02-25 |
$34,301,000 |
| 5594104 |
Anti-obesity proteins |
Margret B. Basinski, Richard D. DiMarchi, David B. Flora, William F. Heath, Jr., James A. Hoffmann +2 more |
1997-01-14 |
$29,464,000 |
| 5569744 |
Anti-obesity proteins |
Margret B. Basinski, Richard D. DiMarchi, David B. Flora, William F. Heath, Jr., James A. Hoffmann +2 more |
1996-10-29 |
$52,853,000 |
| 5567803 |
Anti-obesity proteins |
Margret B. Basinski, Richard D. DiMarchi, David B. Flora, William F. Heath, Jr., James A. Hoffmann +2 more |
1996-10-22 |
$31,279,000 |
| 5559208 |
Anti-obesity proteins |
Margret B. Basinski, Richard D. DiMarchi, William F. Heath, Jr. |
1996-09-24 |
$39,269,000 |
| 5554727 |
Anti-obesity proteins |
Margret B. Basinski, Richard D. DiMarchi, William F. Heath, Jr. |
1996-09-10 |
$37,705,000 |
| 5552524 |
Anti-obesity proteins |
Margret B. Basinski, Richard D. DiMarchi, William F. Heath, Jr. |
1996-09-03 |
$12,735,000 |
| 5552523 |
Anti-obesity proteins |
Margret B. Basinski, Richard D. DiMarchi, William F. Heath, Jr. |
1996-09-03 |
$12,735,000 |
| 5244806 |
DNA encoding novel tissue plasminogen activator derivatives having kringles 1 and 2 deleted, vectors and host cells |
Nils U. Bang, Sheila P. Little, Barbara J. Weigel |
1993-09-14 |
$27,500,000 |
| 5192669 |
Method to produce recombinant proteins using an expression vector comprising transcriptional and translational activating sequences |
Ronald G. Schoner |
1993-03-09 |
$35,390,000 |
| 5190871 |
Use of the site-specific integrating function of phage .phi.C31 |
Karen L. Cox, Stuart A. Kuhstoss, R. Nagaraja Rao, Mark A. Richardson, Eugene T. Seno |
1993-03-02 |
$68,633,000 |
| 5068189 |
"Recombinant DNA vectors encoding a 4""-O-isovaleryl acylase derived from a carbomycin biosynthetic gene, designated carE, for use in streptomyces and other organisms" |
Janet K. Epp |
1991-11-26 |
$49,945,000 |
| 5063158 |
Recombinant DNA expression vector comprising both transcriptional and translational activating sequences |
Ronald G. Schoner |
1991-11-05 |
$27,173,000 |
| 4952502 |
Carbomycin biosynthetic gene, designated carG, for use in streptomyces and other organisms |
Janet K. Epp |
1990-08-28 |
$48,862,000 |
| 4914030 |
Carbomycin resistance-conferring gene, designated carb, for use in streptomyces and other organisms |
Janet K. Epp |
1990-04-03 |
$18,771,000 |
| 4904591 |
Carbomycin resistance-conferring gene, designated cara, for use in streptomyces and other organisms |
Janet K. Epp |
1990-02-27 |
$10,960,000 |
| 4738921 |
Derivative of the tryptophan operon for expression of fused gene products |
Ramamoorthy Belagaje, Janet K. Epp, JoAnn Hoskins, Hansen M. Hsiung, George L. Long |
1988-04-19 |
$66,736,000 |
